Inventor · disambiguated record
Rajeshwar Motheram
Also filed as: MOTHERAM RAJESHWAR
15 granted patents·22 pending applications·135 citations·filing 1999–2024
92Inventor score
Top patents by PatentIndex Score
37 records- 0192US7985733B1Buffer-based method for preparing bivalirudin drug productMEDICINES CO·Filed 2010·Granted Jul 26, 2011·12 cites·17 claims
- 0291US7713928B1Ready-to-use bivalirudin compositionsMEDICINES CO·Filed 2009·Granted May 11, 2010·15 cites·20 claims
- 0390US8658676B2Clevidipine emulsion formulations containing antimicrobial agentsMEDICINES CO·Filed 2013·Granted Feb 25, 2014·6 cites·8 claims
- 0489US9295687B1Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the sameMEDICINES CO·Filed 2015·Granted Mar 29, 2016·9 cites·30 claims
- 0588US7803762B1Ready-to-use bivalirudin compositionsMEDICINES CO·Filed 2009·Granted Sep 28, 2010·10 cites·53 claims
- 0686US2025213540A1Pharmaceutical compositions and methods for producing low impurity concentrations of the sameCHIESI FARM SPA·Filed 2024·Application pending·0 cites
- 0783US11103490B2Clevidipine emulsion formulations containing antimicrobial agentsCHIESI FARM SPA·Filed 2014·Granted Aug 31, 2021·2 cites·8 claims
- 0883US9439921B2Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the sameTHE MEDICINES CO·Filed 2016·Granted Sep 13, 2016·4 cites·26 claims
- 0983US6100302APropofol formulation with enhanced microbial characteristicsBAXTER INT·Filed 1999·Granted Aug 8, 2000·68 cites·9 claims
- 1082US9700575B2Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the sameCHIESI FARM SPA·Filed 2016·Granted Jul 11, 2017·3 cites·26 claims
- 1182US2025057825A1Clevidipine emulsion formulations containing antimicrobial agentsCHIESI FARM SPA·Filed 2024·Application pending·0 cites
- 1280US2023302002A1Pharmaceutical Compositions and Methods for Stabilizing the SameCHISEI FARM S P A·Filed 2023·Application pending·0 cites
- 1379US10039780B2Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the sameCHIESI FARM SPA·Filed 2017·Granted Aug 7, 2018·2 cites·23 claims
- 1479US2025082574A1Injectable compositions of triterpenoid antifungals encapsulated in liposomesSCYNEXIS INC·Filed 2024·Application pending·0 cites
- 1574US2023277455A1Injectable compositions of triterpenoid antifungals encapsulated in liposomesSCYNEXIS INC·Filed 2022·Application pending·0 cites
- 1672US10010537B2Clevidipine emulsion formulations containing antimicrobial agentsMOTHERAM RAJESHWAR·Filed 2011·Granted Jul 3, 2018·4 cites·12 claims
- 1771US2021369694A1Clevidipine emulsion formulations containing antimicrobial agentsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 1871US2022000849A1Pharmaceutical compositions and methods for producing low impurity concentrations of the sameCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 1970US11058672B2Pharmaceutical compositions and methods for producing low impurity concentrations of the sameCHIESI FARM SPA·Filed 2018·Granted Jul 13, 2021·0 cites·11 claims
- 2067US2008275009A1Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereofBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 2166US2020338002A1Injectable compositions of triterpenoid antifungals encapsulated in liposomesSCYNEXIS INC·Filed 2018·Application pending·0 cites
- 2265US12383507B2Clevidipine nanoparticles and pharmaceutical compositions thereofCHIESI FARM SPA·Filed 2022·Granted Aug 12, 2025·0 cites·16 claims
- 2365US2010105743A1Pharmaceutical compositions and methods for stabilizing the sameKRISHNA GOPAL·Filed 2009·Application pending·0 cites
- 2462US2007105867A1Oral administration of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 2561US2019117660A1Pharmaceutical Compositions and Methods for Stabilizing the SameCHIESI FARM SPA·Filed 2018·Application pending·0 cites
- 2659US2010113534A1Pharmaceutical Compositions And Methods For Producing Low Impurity Concentrations Of The SameMOTHERAM RAJESHWAR·Filed 2009·Application pending·0 cites
- 2758US2006057196A1Efavirenz tablet formulation having unique biopharmaceutical characteristicsHUSSAIN MUNIR A·Filed 2005·Application pending·0 cites
- 2857US2014005233A1Pharmaceutical compositions and methods for producing low impurity concentrations of the sameMEDICINES CO·Filed 2013·Application pending·0 cites
- 2956US2012322836A1Pharmaceutical compositions and methods for stabilizing the sameKRISHNA GOPAL·Filed 2012·Application pending·0 cites
- 3055US2003124186A1Efavirenz tablet formulation having unique biopharmaceutical characteristicsFiled 2002·Application pending·0 cites
- 3151US2006251723A1Formulations of a SRC/ABL inhibitorGAO JULIA Z·Filed 2006·Application pending·0 cites
- 3250US2012322835A1Pharmaceutical compositions and methods for producing low impurity concentrations of the sameMOTHERAM RAJESHWAR·Filed 2012·Application pending·0 cites
- 3349US11737989B2Clevidipine nanoparticles and pharmaceutical compositions thereofCHIESI FARM SPA·Filed 2015·Granted Aug 29, 2023·0 cites·24 claims
- 3449US2013122093A1Formulations of a src/abl inhibitorGAO JULIA ZH·Filed 2013·Application pending·0 cites
- 3544US2011046063A1Ready-to-use bivalirudin compositionsPALEPU NAGESH·Filed 2010·Application pending·0 cites
- 3642US2017224662A1Aqueous Formulations and Methods of Preparation and Use ThereofTHE MEDICINES CO·Filed 2017·Application pending·0 cites
- 3741US8754125B2Antimicrobial preservation of propofol emulsionsDING MIN·Filed 2011·Granted Jun 17, 2014·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →